Fabrizio Benedetti

Active 1995–2025

108
Papers
22,465
Citations
79
h-index
107
i10-index

Citations

Citations per year for Fabrizio Benedetti1938: 1 citations1952: 1 citations1978: 1 citations1995: 1 citations1997: 5 citations1998: 8 citations1999: 22 citations2000: 9 citations2001: 21 citations2002: 50 citations2003: 48 citations2004: 68 citations2005: 127 citations2006: 135 citations2007: 170 citations2008: 163 citations2009: 189 citations2010: 191 citations2011: 313 citations2012: 150 citations2013: 241 citations2014: 243 citations2015: 305 citations2016: 215 citations2017: 184 citations2018: 249 citations2019: 672 citations2020: 542 citations2021: 425 citations2022: 408 citations2023: 378 citations2024: 640 citations2025: 442 citations2026: 18 citations1939–1951: no citations, so these years are not shown1953–1977: no citations, so these years are not shown1979–1994: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,299 citing papers, 24.6% of this breakdownUnited Kingdom: 472 citing papers, 8.9% of this breakdownChina: 449 citing papers, 8.5% of this breakdownGermany: 427 citing papers, 8.1% of this breakdownItaly: 322 citing papers, 6.1% of this breakdownNetherlands: 201 citing papers, 3.8% of this breakdownCanada: 191 citing papers, 3.6% of this breakdownAustralia: 179 citing papers, 3.4% of this breakdownSwitzerland: 177 citing papers, 3.4% of this breakdownFrance: 159 citing papers, 3% of this breakdownDenmark: 112 citing papers, 2.1% of this breakdownSweden: 107 citing papers, 2% of this breakdown
0%24.6%Other 22.5%

Fields

  • Medicine44.4%
  • Neuroscience30.9%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Immunology and Microbiology6.9%
  • Psychology4.9%
  • Health Professions1.4%
  • Other3.7%

Topics

  • Pain Management and Placebo Effect11.4%
  • Pain Mechanisms and Treatments6.2%
  • Cancer Immunotherapy and Biomarkers3.3%
  • Musculoskeletal pain and rehabilitation2.3%
  • Acupuncture Treatment Research Studies2.2%
  • Immune cells in cancer2.1%
  • Other72.5%

Coauthors

All papers

Open in search
  1. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sara I. Pai, Moshe Sade-Feldman, Mikaël J. Pittet - Science 2023 cited by 614

  2. PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grégory Verdeil, Lana E. Kandalaft, Julien Dagher, Jesús Corría-Osorio, Marie‐Agnès Doucey, Ping‐Chih Ho, Alexandre Harari, Nicola Vannini, Jan P. Böttcher, Denarda Dangaj Laniti, George Coukos - Nature 2024 cited by 197

  3. Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Zimmermann, Christine Sempoux, Urania Dafni, Alexandre Harari, Lana E. Kandalaft, Santiago J. Carmona, Denarda Dangaj Laniti, Melita Irving, George Coukos - Cancer Discovery 2021 cited by 423

  4. Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Periklis Foukas, Daniel J. Powell, Sylvie Rusakiewicz, Marie‐Agnès Doucey, Denarda Dangaj Laniti, George Coukos - Cancer Cell 2021 cited by 194

  5. Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Psychotherapy and Psychosomatics 2018 cited by 565

  6. Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maurice Matter, Veronica Aedo, Clarisse Dromain, Jesús Corría-Osorio, Stéphanie Tissot, Lana E. Kandalaft, Raphaël Gottardo, Mikaël J. Pittet, Christine Sempoux, Olivier Michielin, Urania Dafni, Lionel Trueb, Alexandre Harari, Denarda Dangaj Laniti, George Coukos - Science Immunology 2024 cited by 91

  7. Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George Coukos, Alexandre Harari - Nature Communications 2023 cited by 68

  8. A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2024 cited by 86

  9. Biological, clinical, and ethical advances of placebo effects

    Authors: , , , - The Lancet 2010 cited by 1,263

  10. Neurobiological Mechanisms of the Placebo Effect

    Authors: , , , , - Journal of Neuroscience 2005 cited by 773

  11. A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought

    Authors: , , - Annual Review of Psychology 2007 cited by 1,153

  12. Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems

    Authors: , - Journal of Neuroscience 1999 cited by 909

  13. Placebo Effects: From the Neurobiological Paradigm to Translational Implications

    Authors: - Neuron 2014 cited by 311

  14. Context matters: the psychoneurobiological determinants of placebo, nocebo and context-related effects in physiotherapy

    Authors: , , , , - Archives of Physiotherapy 2020 cited by 152

  15. Placebo and the New Physiology of the Doctor-Patient Relationship

    Authors: - Physiological Reviews 2013 cited by 485

  16. How Placebos Change the Patient's Brain

    Authors: , , - Neuropsychopharmacology 2010 cited by 448

  17. Placebo analgesia induced by social observational learning

    Authors: , - Pain 2009 cited by 416

  18. Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid α-synuclein fibrils

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 114

  19. What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Psychotherapy and Psychosomatics 2020 cited by 96

  20. Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses

    Authors: , , , , , - Journal of Neuroscience 2003 cited by 796

  21. The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect

    Authors: , , , - Journal of Neuroscience 2006 cited by 419

  22. Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments

    Authors: - The Annual Review of Pharmacology and Toxicology 2007 cited by 385

  23. Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Denarda Dangaj Laniti, Alexandre Harari, George Coukos - Immunity 2024 cited by 43

  24. Overt versus covert treatment for pain, anxiety, and Parkinson's disease

    Authors: , , , - The Lancet Neurology 2004 cited by 547